This contribution represents the second of two parts of guidelines for clinical use of tumour biomarkers, reporting in schematic tables the evidence-based information available for different neoplastic pathologies (the first part was published on Biochim Clin 2011;35:394-403). Particularly, the following neoplastic conditions are considered in this document: testicular seminoma and non-seminoma, cervical uterine cancer, ovarian and renal cell carcinomas, breast cancer, melanoma, and neuroendocrine tumors.
|Translated title of the contribution||Guidelines for clinical use of biomarkers of different neoplastic diseases - Part II|
|Number of pages||9|
|Publication status||Published - Dec 2011|
ASJC Scopus subject areas
- Clinical Biochemistry
- Biochemistry, medical
- Medical Laboratory Technology